IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.55M | -6.16M | -7.09M | -8.63M | -8.56M |
| Total Depreciation and Amortization | 669.00K | 702.00K | 690.00K | 631.00K | 632.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 831.00K | 825.00K | 1.81M | 1.17M | 1.24M |
| Change in Net Operating Assets | 928.00K | 605.00K | -1.52M | 736.00K | -1.23M |
| Cash from Operations | -3.12M | -4.03M | -6.11M | -6.09M | -7.92M |
| Capital Expenditure | -- | -33.00K | 0.00 | -83.00K | -71.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -33.00K | 0.00 | -83.00K | -71.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -225.00K | -219.00K | -213.00K | -174.00K | -188.00K |
| Issuance of Common Stock | 4.12M | 11.23M | 289.00K | 3.55M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 181.00K | -181.00K | 0.00 | -89.00K |
| Cash from Financing | 3.89M | 11.19M | -105.00K | 3.38M | -277.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 771.00K | 7.13M | -6.22M | -2.80M | -8.27M |